Opportunities and challenges of engineered exosomes for diabetic wound healing DOI Creative Commons

Lin Shi,

Song Dawei,

Cong Meng

et al.

Giant, Journal Year: 2024, Volume and Issue: 18, P. 100251 - 100251

Published: March 6, 2024

The treatment of diabetic wounds is a major challenge faced by the medical system, and there growing interest in developing innovative therapies to accelerate wound healing. Regenerative medicine with cells has shown promising potential skin repair, regenerative properties primarily attributed paracrine effects secreted products, including exosomes. Compared cell-based approaches, using exosomes as cell-free therapy for chronic several advantages. Exosomes can regulate intercellular communication releasing their contents, mRNA, miRNA, lipids, proteins, which further promote are well explored biomedical application owing advantages such biocompatibility low immunogenicity. However, common method exosome administration through injection, but due rapid clearance rate body, maintaining necessary therapeutic concentration around challenging. Therefore, it develop new biocompatible scaffold carrier extracellular vesicles, allowing them sustain at non-healing sites continuously Engineered kinds modified internal treated molecules, surface decoration or delivered engineered platform. In addition, some researchers have processed exosomes, known decoration, delivery platforms. regular greater promoting this review, we summarize molecular mechanisms from different sources varying modifications Advantages limitations repair were also discussed. Finally, highlight challenges future development directions translating our knowledge into clinical practice.

Language: Английский

Plant exosome nanovesicles (PENs): green delivery platforms DOI
Min Cao,

Ningning Diao,

Xiaolu Cai

et al.

Materials Horizons, Journal Year: 2023, Volume and Issue: 10(10), P. 3879 - 3894

Published: Jan. 1, 2023

Structure of plant-derived vesicles and their bioactive applications. Created with BioRender.com

Language: Английский

Citations

74

Platinum Nanoparticles Regulated V2C MXene Nanoplatforms with NIR‐II Enhanced Nanozyme Effect for Photothermal and Chemodynamic Anti‐Infective Therapy DOI
Xiaojun He,

Ya Lv,

Yanling Lin

et al.

Advanced Materials, Journal Year: 2024, Volume and Issue: 36(25)

Published: March 12, 2024

Abstract Given the challenge of multidrug resistance in antibiotics, non‐antibiotic–dependent antibacterial strategies show promise for anti‐infective therapy. V 2 C MXene‐based nanomaterials have demonstrated strong biocompatibility and photothermal conversion efficiency (PCE) therapy (PTT). However, limitation MXene's laser irradiation to near‐infrared region I (NIR‐I) restricts tissue penetration, making it difficult achieve complete bacterial eradication with single‐effect therapeutic strategies. To address this, Pt nanoparticles (Pt NPs) are attached C, forming artificial nanoplatforms (Pt@V C). Pt@V exhibits enhanced PCE (59.6%) a longer (NIR‐II) due surface plasmon resonance effect NPs C. Notably, displays dual enzyme‐like activity chemodynamic (CDT) NIR‐II activity. The biocatalytic mechanism is elucidated using density functional theory. In an vivo animal model, effectively eliminates methicillin‐resistant Staphylococcus aureus from deep‐seated tissues subcutaneous abscesses keratitis environments, accelerating abscess resolution promoting wound cornea healing through synergistic effects PTT/CDT. Transcriptomic analysis reveals that targets inflammatory pathways, providing insight into its mechanism. This study presents promising approach involving hyperthermia‐amplified biocatalysis MXene nanocomposites.

Language: Английский

Citations

70

Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications DOI Creative Commons
Jiaqi Tian,

Zhengpu Han,

Dandan Song

et al.

International Journal of Nanomedicine, Journal Year: 2023, Volume and Issue: Volume 18, P. 7923 - 7940

Published: Dec. 1, 2023

Exosomes are nano-sized membrane vesicles that transfer bioactive molecules between cells and modulate various biological processes under physiological pathological conditions. By applying bioengineering technologies, exosomes can be modified to express specific markers or carry therapeutic cargo emerge as novel platforms for the treatment of cancer, neurological, cardiovascular, immune, infectious diseases. However, there many challenges uncertainties in clinical translation exosomes. This review aims provide an overview recent advances engineered exosomes, with a special focus on methods strategies loading drugs into pros cons different methods, optimization exosome production based encapsulated. Moreover, we also summarize current applications prospects well potential risks limitations need addressed engineering, including standardization preparation engineering protocols, quality quantity control drug release, immunogenicity cytotoxicity Overall, represent exciting frontier nanomedicine, but they still face large-scale production, maintenance storage stability, translation. With continuous this field, exosome-based formulation could offer great promise targeted human

Language: Английский

Citations

67

Dacarbazine-primed carbon quantum dots coated with breast cancer cell-derived exosomes for improved breast cancer therapy DOI
Pratiksha Tiwari, Ravi Prakash Shukla, Krishna Yadav

et al.

Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 365, P. 43 - 59

Published: Nov. 19, 2023

Language: Английский

Citations

57

Engineered Living Materials for Advanced Diseases Therapy DOI Open Access
Dong Xue, Wei Wu, Pei Pan

et al.

Advanced Materials, Journal Year: 2023, Volume and Issue: unknown

Published: July 12, 2023

Abstract Natural living materials serving as biotherapeutics exhibit great potential for treating various diseases owing to their immunoactivity, tissue targeting, and other biological activities. In this review, the recent developments in engineered materials, including mammalian cells, bacteria, viruses, fungi, microalgae, plants, active derivatives that are used summarized. Further, future perspectives challenges of such material‐based discussed provide considerations advances biomedical applications.

Language: Английский

Citations

56

Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application DOI Creative Commons
Qian Yang, Shisheng Li,

Haibo Ou

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Jan. 28, 2024

Malignancy is a major public health problem and among the leading lethal diseases worldwide. Although current tumor treatment methods have therapeutic effect to certain extent, they still some shortcomings such as poor water solubility, short half-life, local systemic toxicity. Therefore, how deliver agent so realize safe effective anti-tumor therapy become urgently be solved in this field. As medium of information exchange material transport between cells, exosomes are considered promising drug delivery carrier due their nano-size, good biocompatibility, natural targeting, easy modification. In review, we summarize recent advances isolation, identification, loading, modification carriers for alongside application therapy. Basic knowledge exosomes, biogenesis, sources, characterization methods, also introduced herein. addition, challenges related use vehicles discussed, along with future trends. This review provides scientific basis exosome systems oncological

Language: Английский

Citations

51

Beyond Extracellular Vesicles: Hybrid Membrane Nanovesicles as Emerging Advanced Tools for Biomedical Applications DOI Creative Commons
Meng Sun,

Jiani Yang,

Yueyun Fan

et al.

Advanced Science, Journal Year: 2023, Volume and Issue: 10(32)

Published: Sept. 25, 2023

Extracellular vesicles (EVs), involved in essential physiological and pathological processes of the organism, have emerged as powerful tools for disease treatment owing to their unique natural biological characteristics artificially acquired advantages. However, limited targeting ability, insufficient production yield, low drug-loading capability simplex EVs greatly hindered development clinical translation. Therefore, establishment multifunctional hybrid membrane nanovesicles (HMNVs) with favorable adaptability flexibility has become key expanding practical application EVs. This timely review summarizes current progress HMNVs biomedical applications. Different preparation strategies including physical, chemical, chimera approaches are first discussed. then individually describes diverse types based on homologous or heterologous cell substances, a fusion liposome, well bacterial membrane. Subsequently, specific emphasis is placed highlight applications toward various diseases representative examples. Finally, ongoing challenges prospects currently developed translational briefly presented. will not only stimulate broad interest among researchers from disciplines but also provide valuable insights promising nanoplatforms precision medicine.

Language: Английский

Citations

46

Exosome regulation of immune response mechanism: Pros and cons in immunotherapy DOI Creative Commons

Julien Milon Essola,

Jun Zhang,

Haiyin Yang

et al.

Bioactive Materials, Journal Year: 2023, Volume and Issue: 32, P. 124 - 146

Published: Oct. 4, 2023

Due to its multiple features, including the ability orchestrate remote communication between different tissues, exosomes are extracellular vesicles arousing highest interest in scientific community. Their size, established as an average of 30-150 nm, allows them be easily uptaken by most cells. According type cells-derived exosomes, they may carry specific biomolecular cargoes used reprogram cells interacting with. In certain circumstances, stimulate immune response facilitating or amplifying release foreign antigens-killing cells, inflammatory factors, antibodies (immune activation). Meanwhile, other cases, efficiently malignant elements such cancer mislead recognition mechanism, carrying and transferring their cancerous distant healthy thus contributing antigenic invasion suppression). Exosome dichotomic patterns upon system regulation present broad advantages immunotherapy. Its perfect comprehension, from early biogenesis interaction with recipient will promote a significant enhancement immunotherapy employing molecular biology, nanomedicine, nanotechnology.

Language: Английский

Citations

45

TME-Related Biomimetic Strategies Against Cancer DOI Creative Commons
Cheng Peng,

Yilin Xu,

Jing Wu

et al.

International Journal of Nanomedicine, Journal Year: 2024, Volume and Issue: Volume 19, P. 109 - 135

Published: Jan. 1, 2024

Abstract: The tumor microenvironment (TME) plays an important role in various stages of generation, metastasis, and evasion immune monitoring treatment. TME targeted therapy is based on components, related pathways or active molecules as therapeutic targets. Therefore, environmental differences between normal cells has been widely studied. Biomimetic nanocarriers with low clearance, immunogenicity, high targeting have enormous potential This review introduces the composition characteristics TME, including cancer‑associated fibroblasts (CAFs), extracellular matrix (ECM), blood vessels, non-tumor cells, latest research progress biomimetic nanoparticles (NPs) TME. It also discusses opportunities challenges clinical transformation nanoparticles. Keywords: nanoparticles, delivery system, therapy, cell membrane-coating

Language: Английский

Citations

36

Targeting triple negative breast cancer stem cells using nanocarriers DOI Creative Commons
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu

et al.

Discover Nano, Journal Year: 2024, Volume and Issue: 19(1)

Published: March 7, 2024

Abstract Breast cancer is a complex and heterogeneous disease, encompassing various subtypes characterized by distinct molecular features, clinical behaviors, treatment responses. Categorization of based on the presence or absence estrogen receptor (ER), progesterone (PR), human epidermal growth factor 2 (HER2), leading to such as luminal A, B, HER2-positive, triple-negative breast (TNBC). TNBC, comprising around 20% all cancers, lacks expression ER, PR, HER2 receptors, rendering it unresponsive targeted therapies presenting significant challenges in treatment. TNBC associated with aggressive behavior, high rates recurrence, resistance chemotherapy. Tumor initiation, progression, are attributed stem cells (BCSCs), which possess self-renewal, differentiation, tumorigenic potential. Surface markers, self-renewal pathways (Notch, Wnt, Hedgehog signaling), apoptotic protein (Bcl-2), angiogenesis inhibition (VEGF inhibitors), immune modulation (cytokines, checkpoint inhibitors) among key targets discussed this review. However, targeting BCSC subpopulation presents challenges, including off-target effects, low solubility, bioavailability anti-BCSC agents. Nanoparticle-based offer promising approach target cellular processes implicated survival BSCS TNBC. In review, we explore nanocarrier-based approaches for BCSCs aiming overcome these improve outcomes patients. These nanoparticle-based therapeutic strategies hold promise addressing gap delivering while minimizing systemic toxicity enhancing efficacy. Graphical abstract

Language: Английский

Citations

20